Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer鈥檚 products are justly used in local region or countries.
The global Human Fibrinogen market is projected to grow from US$ 929.6 million in 2024 to US$ 2207 million by 2030, at a Compound Annual Growth Rate (CAGR) of 15.5% during the forecast period.
Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.
Report Covers:
This report presents an overview of global market for Human Fibrinogen, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Fibrinogen, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Human Fibrinogen, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Fibrinogen sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Fibrinogen market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Fibrinogen sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma
Segment by Type
Human Fibrinogen Concentrate
Animal Fibrinogen Concentrate
Segment by Application
Congenital Fibrinogen Deficiency
Surgical Procedures
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Fibrinogen in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Human Fibrinogen manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Fibrinogen sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Human Fibrinogen Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Human Fibrinogen 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Human Fibrinogen Concentrate
1.2.3 Animal Fibrinogen Concentrate
1.3 麻豆原创 by Application
1.3.1 Global Human Fibrinogen 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Congenital Fibrinogen Deficiency
1.3.3 Surgical Procedures
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Fibrinogen Sales Estimates and Forecasts 2019-2030
2.2 Global Human Fibrinogen Revenue by Region
2.2.1 Global Human Fibrinogen Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Human Fibrinogen Revenue by Region (2019-2024)
2.2.3 Global Human Fibrinogen Revenue by Region (2025-2030)
2.2.4 Global Human Fibrinogen Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Human Fibrinogen Sales Estimates and Forecasts 2019-2030
2.4 Global Human Fibrinogen Sales by Region
2.4.1 Global Human Fibrinogen Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Human Fibrinogen Sales by Region (2019-2024)
2.4.3 Global Human Fibrinogen Sales by Region (2025-2030)
2.4.4 Global Human Fibrinogen Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Human Fibrinogen Sales by Manufacturers
3.1.1 Global Human Fibrinogen Sales by Manufacturers (2019-2024)
3.1.2 Global Human Fibrinogen Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Fibrinogen in 2023
3.2 Global Human Fibrinogen Revenue by Manufacturers
3.2.1 Global Human Fibrinogen Revenue by Manufacturers (2019-2024)
3.2.2 Global Human Fibrinogen Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Fibrinogen Revenue in 2023
3.3 Global Key Players of Human Fibrinogen, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Human Fibrinogen Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Fibrinogen 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Fibrinogen, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Fibrinogen, Product Offered and Application
3.8 Global Key Manufacturers of Human Fibrinogen, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Human Fibrinogen Sales by Type
4.1.1 Global Human Fibrinogen Historical Sales by Type (2019-2024)
4.1.2 Global Human Fibrinogen Forecasted Sales by Type (2025-2030)
4.1.3 Global Human Fibrinogen Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Human Fibrinogen Revenue by Type
4.2.1 Global Human Fibrinogen Historical Revenue by Type (2019-2024)
4.2.2 Global Human Fibrinogen Forecasted Revenue by Type (2025-2030)
4.2.3 Global Human Fibrinogen Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Human Fibrinogen Price by Type
4.3.1 Global Human Fibrinogen Price by Type (2019-2024)
4.3.2 Global Human Fibrinogen Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Human Fibrinogen Sales by Application
5.1.1 Global Human Fibrinogen Historical Sales by Application (2019-2024)
5.1.2 Global Human Fibrinogen Forecasted Sales by Application (2025-2030)
5.1.3 Global Human Fibrinogen Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Human Fibrinogen Revenue by Application
5.2.1 Global Human Fibrinogen Historical Revenue by Application (2019-2024)
5.2.2 Global Human Fibrinogen Forecasted Revenue by Application (2025-2030)
5.2.3 Global Human Fibrinogen Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Human Fibrinogen Price by Application
5.3.1 Global Human Fibrinogen Price by Application (2019-2024)
5.3.2 Global Human Fibrinogen Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Human Fibrinogen 麻豆原创 Size by Type
6.1.1 US & Canada Human Fibrinogen Sales by Type (2019-2030)
6.1.2 US & Canada Human Fibrinogen Revenue by Type (2019-2030)
6.2 US & Canada Human Fibrinogen 麻豆原创 Size by Application
6.2.1 US & Canada Human Fibrinogen Sales by Application (2019-2030)
6.2.2 US & Canada Human Fibrinogen Revenue by Application (2019-2030)
6.3 US & Canada Human Fibrinogen 麻豆原创 Size by Country
6.3.1 US & Canada Human Fibrinogen Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Human Fibrinogen Sales by Country (2019-2030)
6.3.3 US & Canada Human Fibrinogen Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Human Fibrinogen 麻豆原创 Size by Type
7.1.1 Europe Human Fibrinogen Sales by Type (2019-2030)
7.1.2 Europe Human Fibrinogen Revenue by Type (2019-2030)
7.2 Europe Human Fibrinogen 麻豆原创 Size by Application
7.2.1 Europe Human Fibrinogen Sales by Application (2019-2030)
7.2.2 Europe Human Fibrinogen Revenue by Application (2019-2030)
7.3 Europe Human Fibrinogen 麻豆原创 Size by Country
7.3.1 Europe Human Fibrinogen Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Human Fibrinogen Sales by Country (2019-2030)
7.3.3 Europe Human Fibrinogen Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Human Fibrinogen 麻豆原创 Size
8.1.1 China Human Fibrinogen Sales (2019-2030)
8.1.2 China Human Fibrinogen Revenue (2019-2030)
8.2 China Human Fibrinogen 麻豆原创 Size by Application
8.2.1 China Human Fibrinogen Sales by Application (2019-2030)
8.2.2 China Human Fibrinogen Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Human Fibrinogen 麻豆原创 Size by Type
9.1.1 Asia Human Fibrinogen Sales by Type (2019-2030)
9.1.2 Asia Human Fibrinogen Revenue by Type (2019-2030)
9.2 Asia Human Fibrinogen 麻豆原创 Size by Application
9.2.1 Asia Human Fibrinogen Sales by Application (2019-2030)
9.2.2 Asia Human Fibrinogen Revenue by Application (2019-2030)
9.3 Asia Human Fibrinogen Sales by Region
9.3.1 Asia Human Fibrinogen Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Human Fibrinogen Revenue by Region (2019-2030)
9.3.3 Asia Human Fibrinogen Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Fibrinogen 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Human Fibrinogen Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Human Fibrinogen Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Human Fibrinogen 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Human Fibrinogen Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Human Fibrinogen Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Human Fibrinogen Sales by Country
10.3.1 Middle East, Africa and Latin America Human Fibrinogen Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Human Fibrinogen Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Human Fibrinogen Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 CSL Behring Human Fibrinogen Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Behring Recent Developments
11.2 LFB Group
11.2.1 LFB Group Company Information
11.2.2 LFB Group Overview
11.2.3 LFB Group Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 LFB Group Human Fibrinogen Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 LFB Group Recent Developments
11.3 Shanghai RAAS Blood Products
11.3.1 Shanghai RAAS Blood Products Company Information
11.3.2 Shanghai RAAS Blood Products Overview
11.3.3 Shanghai RAAS Blood Products Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Shanghai RAAS Blood Products Human Fibrinogen Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Shanghai RAAS Blood Products Recent Developments
11.4 Jiangxi Boya Bio-Pharmaceutical
11.4.1 Jiangxi Boya Bio-Pharmaceutical Company Information
11.4.2 Jiangxi Boya Bio-Pharmaceutical Overview
11.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
11.5 Hualan Biological Engineering
11.5.1 Hualan Biological Engineering Company Information
11.5.2 Hualan Biological Engineering Overview
11.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Hualan Biological Engineering Human Fibrinogen Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hualan Biological Engineering Recent Developments
11.6 Harbin Pacific Biopharmaceutical
11.6.1 Harbin Pacific Biopharmaceutical Company Information
11.6.2 Harbin Pacific Biopharmaceutical Overview
11.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Harbin Pacific Biopharmaceutical Recent Developments
11.7 GREEN CROSS
11.7.1 GREEN CROSS Company Information
11.7.2 GREEN CROSS Overview
11.7.3 GREEN CROSS Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 GREEN CROSS Human Fibrinogen Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GREEN CROSS Recent Developments
11.8 Shanghai XinXing Medical
11.8.1 Shanghai XinXing Medical Company Information
11.8.2 Shanghai XinXing Medical Overview
11.8.3 Shanghai XinXing Medical Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Shanghai XinXing Medical Human Fibrinogen Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Shanghai XinXing Medical Recent Developments
11.9 Octapharma
11.9.1 Octapharma Company Information
11.9.2 Octapharma Overview
11.9.3 Octapharma Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Octapharma Human Fibrinogen Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Octapharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Fibrinogen Industry Chain Analysis
12.2 Human Fibrinogen Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Fibrinogen Production Mode & Process
12.4 Human Fibrinogen Sales and 麻豆原创ing
12.4.1 Human Fibrinogen Sales Channels
12.4.2 Human Fibrinogen Distributors
12.5 Human Fibrinogen Customers
13 麻豆原创 Dynamics
13.1 Human Fibrinogen Industry Trends
13.2 Human Fibrinogen 麻豆原创 Drivers
13.3 Human Fibrinogen 麻豆原创 Challenges
13.4 Human Fibrinogen 麻豆原创 Restraints
14 Key Findings in The Global Human Fibrinogen Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma
听
听
*If Applicable.